Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck.

导出 OA

翻译打印收藏纠错

第一作者： Brian J,Park

第一单位： Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, United States.

作者： Brian J,Park ^[1] ; Austin K,Mattox ^[2] ; Daniel,Clayburgh ^[3] ; Mihir,Patel ^[4] ; R Bryan,Bell ^[5] ; Bevan,Yueh ^[6] ; Rom,Leidner ^[5] ; Hong,Xiao ^[7] ; Marcus,Couey ^[7] ; Shiting,Li ^[8] ; Tingting,Qin ^[8] ; Maureen A,Sartor ^[8] ; Belinda,Cairns ^[9] ; Tracy,MacDonough ^[9] ; Kyle,Halliwill ^[9] ; Daniel,Deschler ^[1] ; Derrick T,Lin ^[1] ; William C,Faquin ^[10] ; Peter M,Sadow ^[10] ; Sara I,Pai ^[11]

作者单位： Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, United States. ^[1] Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States. ^[2] Department of Otolaryngology-Head and Neck Surgery, Oregon Health & Science University, Portland, OR, United States. ^[3] Department of Otolaryngology-Head and Neck Surgery, Emory University, Atlanta, Georgia. ^[4] Earle A. Chiles Research Institute in the Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, OR, United States. ^[5] Department of Otolaryngology, University of Minnesota, Minneapolis, MN, United States. ^[6] Department of Pathology, Providence Health and Services-Oregon, Portland, OR, United States. ^[7] Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, United States. ^[8] AbbVie Biotherapeutics, Redwood City, CA, United States. ^[9] Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. ^[10] Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, United States. Electronic address: sara.pai@mgh.harvard.edu. ^[11]

主题词人类(Humans);肿瘤复发, 局部(Neoplasm Recurrence, Local);头颈部肿瘤(Head and Neck Neoplasms);癌, 鳞状细胞(Carcinoma, Squamous Cell)

DOI 10.1016/j.oraloncology.2022.106183

PMID 36215771

发布时间 2023-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Oral oncology

2022年135卷

106183页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck.

Oral oncology

相似文献

Oral oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck.

Oral oncology

相似文献

Oral oncology

相关期刊

检索历史清除